Malignant liver disease in alpha 1-antitrypsin deficiency.
Poley
J R
JR
Children's Hospital of the King's Daughters, Department of Pediatrics, Eastern Virginia Medical School, Medical College of Hampton Roads, Norfolk.
D000328:Adult; D000483:Alleles; D006528:Carcinoma, Hepatocellular / Q000097:blood / Q000235:genetics*; D018281:Cholangiocarcinoma / Q000097:blood / Q000235:genetics*; D002869:Chromosome Aberrations / Q000235:genetics; D025063:Chromosome Disorders; D002908:Chronic Disease; D016158:Genes, p53 / Q000235:genetics; D011905:Genes, ras / Q000235:genetics; D006579:Heterozygote; D006801:Humans; D008107:Liver Diseases / Q000097:blood / Q000235:genetics*; D008113:Liver Neoplasms / Q000097:blood / Q000235:genetics*; D009154:Mutation; D015689:Oncogene Protein p21(ras) / Q000032:analysis; D010641:Phenotype; D011230:Precancerous Conditions; D012307:Risk Factors; D016159:Tumor Suppressor Protein p53 / Q000032:analysis; D019896:alpha 1-Antitrypsin Deficiency
D016159:Tumor Suppressor Protein p53; D015689:Oncogene Protein p21(ras)